Date: November 3rd-4th, 2005

Place: Chonnam National University Hwasun Hospital, Hwasun, Jeonnam, KOREA

주관:
화순전남대병원 암센터 (Cancer Center, Chonnam National University Hwasun Hospital)
화순전남대병원 암연구소 (Cancer Research Institute, Chonnam National University Hwasun Hospital)
임상백신연구개발사업단 (Clinical Vaccine R&D Center)

후원:
장관계감염세균유전체연구센터(Genomic Research Center for Enteropathogenic Bacteria)
국제백신연구소 (International Vaccine Institute)
한국수지상세포연구회 (Korean Dendritic Cell Academic Society)



November 3, 2005
Place: Chonnam National University Hwasun Hospital, Jeonnam, Korea

[Opening Remark] 9:00-9:30
Sang-Hyeoung Kim (General Director, Chonnam National University Hospital)
Joon-Haeng Rhee (Clinical Vaccine R&D Center)

9:30-10:20 A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense
Hiroshi Kiyono (Dvision of Mucosal Immunology Dept. of Microbiology and Immunology,
The Institute of Medical Science The University of Tokyo)

10:20-11:10 Antimicrobial resistance in Streptococcus pneumoniae : current status and preventive strategies
JH Song (Dept. of Internal Medicine, Sungkyunkwan University Medical College, Korea)

11:10-12:00 War and Peace at Mucosal Immune System: Progress of Shigella Vaccine
MN Kwon (Mucosal Immunology Section, International Vaccine Institute, Korea)

12:00-1:30 Lunch Break

1:30-2:20 Enhanced responses of glycosylphosphatidylinositol anchor-deficient T lymphocytes
Taroh Kinoshita (Department of Immunoregulation Osaka University, Suita Osaka, Japan)

2:20-3:10 Animal Coronavirus vaccines and lessons from SARS
Linda Saif (Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio, USA)

3:10-3:40 Coffee Break

3:40-4:30 Bacterial infectious disease control by vaccine development
Roy Curtiss, III ( Department of Biology, Washington University, Campus Box 1137, One Brookings Drive, St. Louis, MO, USA)

4:30-5:20 Immune induction of ppGpp-defective mutant Salmonella
Hyon E Choy (Dept. of Microbiology, Chonnam National University, Korea)

November 4, 2005 – Cell therapy and cancer vaccine
Place: Chonnam National University Hwasun Hospital, Jeonnam, Korea

[Opening Remark] 9:00-9:20
Heoung-Keun Kang (General Director, Chonnam National University Hwasun Hospital)
Kyung-Yeon Yoo (Cancer Research Institute, Chonnam National University Hwasun Hospital)

[Chairman: Yong-Soo Bae (Biological Sciences, Sungkyunkwan University)]
9:20-10:20 Dendritic cell cancer vaccine – progress from the laboratory to the clinic
Hart DNJ (Dendritic cell laboratory, Mater Medical Research Institute,
South Brisbane QLD, Australia)

[Chairman: Hyun-Cheol Lee (Dean, Chonnam National University Medical School)]
10:20-11:10 Development of CD40-based Anti-Multiple Myeloma Vaccination Strategies
Gerrard Teoh (Department of Haematology, Singapore General Hospital,
Singapore)

[Chairman: Tai-Gyu Kim (College of Medicine, The Catholic University of Korea)]
11:10-11:40 CD4+ T cells are critical for the anti-tumor adaptive immune response initiated by
α-galactosyl ceramide stimulated NKT cells
Se-Ho Park (School of Life Sciences & Biotechnology, Korea University, Korea)
11:40-12:10 Dendritic cells transfected with epitope-based DNA vaccine vector recruit antigen specific
memory CTLs from chronic hepatitis C patients in vitro.
Yu-Kyeong Hwang (Division of Immunotherapy, Mogam Biotechnology Institute, Korea)


[Lunch] 12:20-13:20

[Chairman: Kyung-Yeon Yoo (Cancer Research Institute, Chonnam National University Hwasun Hospital)]
13:20-14:10 Non-invasive imaging of stem cell therapy
Wu JC (Cardiovascular medicine, Stanford University School of Medicine, USA)
14:10-14:40 Imaging bacteriolytic therapy
Jung-Joon Min (Dept. of Nuclear Medicine, Chonnam National University Hwasun Hospital, Korea)

[Coffee Break] 14:40-15:00
[Chairman: Min-Geol Lee (Department of Dermatology, Yonsei University)]
15:00-15:50 Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed
dendritic cells
Akiyama Y (Immunotherapy division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan)
15:50-16:20 Phase I/II Study of Tumor Lysate-pulsed Autologous Dendritic Cells (CreaVax-RCC) for
Metastatic Renal Cell Carcinoma
Chul Won Jung (Dept. of Medicine, Samsung Medical Center, Sungkyunkwan University, Korea)
16:20-16:50 Immunotherapy using dendritic cells against acute myeloid leukemia
Je-Jung Lee (Dept. of Hematology-Oncology, Chonnam National University Hwasun Hospital, Korea)

[Closing Remark] 16:50 Young-Jin Kim (Cancer Center, Chonnam National University Hwasun Hospital)